Phase 2 Study of Erlotinib Plus Pemetrexed/Cisplatin Treating Lung Adenocarcinoma With Brain Metastases
Phase of Trial: Phase II
Latest Information Update: 09 Sep 2015
At a glance
- Drugs Erlotinib (Primary) ; Pemetrexed (Primary) ; Cisplatin
- Indications Brain metastases; Lung cancer
- Focus Therapeutic Use
- 09 Sep 2015 Results presented at the 16th World Conference on Lung Cancer.
- 25 Jan 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jun 2013 Planned number of patients changed from 90 to 60 as reported by ClinicalTrials.gov.